Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
CTR20262373 KH-607 Depressive Disorder Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262373 KH-607 Depressive Disorder Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262373 clinical trial report covering KH-607, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07677878 Blinatumomab Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07677878 Blinatumomab Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07677878 clinical trial report covering Blinatumomab, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
CTR20262540 SYH2053 Renal Insufficiency Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262540 SYH2053 Renal Insufficiency Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262540 clinical trial report covering SYH2053, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07677917 Dexmedetomidine Hydrochloride Agitation Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07677917 Dexmedetomidine Hydrochloride Agitation Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07677917 clinical trial report covering Dexmedetomidine Hydrochloride, Phase 1, endpoints, sponsor, geography, readout timing and development white spac
Read →
CTR20262459 Group B meningitis vaccine(Delonix Bioworks) Meningitis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262459 Group B meningitis vaccine(Delonix Bioworks) Meningitis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262459 clinical trial report covering Group B meningitis vaccine(Delonix Bioworks), Phase 1, endpoints, sponsor, geography, readout timing and develop
Read →
CTR20262469 Tinengotinib Advanced Malignant Solid Neoplasm Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262469 Tinengotinib Advanced Malignant Solid Neoplasm Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262469 clinical trial report covering Tinengotinib, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07679919 LMY-922 Hairy Cell Leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07679919 LMY-922 Hairy Cell Leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07679919 clinical trial report covering LMY-922, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07679334 Pacritinib Polycythemia Vera Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07679334 Pacritinib Polycythemia Vera Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07679334 clinical trial report covering Pacritinib, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
CTR20262505 NTQ5082 Hemoglobinuria, Paroxysmal Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262505 NTQ5082 Hemoglobinuria, Paroxysmal Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262505 clinical trial report covering NTQ5082, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
CTR20262423 Alpha-0261 Chronic Urticaria Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262423 Alpha-0261 Chronic Urticaria Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262423 clinical trial report covering Alpha-0261, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
CTR20262530 Girocitinib Urticaria Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262530 Girocitinib Urticaria Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262530 clinical trial report covering Girocitinib, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07681479 HRS-9057 Body fluid retention Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07681479 HRS-9057 Body fluid retention Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07681479 clinical trial report covering HRS-9057, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →